Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
As of close of business last night, Alignment Healthcare Inc’s stock clocked out at $16.48, up 0.61% from its previous closing price of $16.38. In other words, the price has increased by $0.61 from its previous closing price. On the day, 1.37 million shares were traded. ALHC stock price reached its highest trading level at $16.56 during the session, while it also had its lowest trading level at $16.015.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Goldman on October 14, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On August 25, 2025, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $21.
Barclays Upgraded its Underweight to Equal Weight on July 31, 2025, while the target price for the stock was maintained at $13.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 11 ’25 when Joseph Konowiecki bought 5,000 shares for $16.33 per share.
KONOWIECKI JOSEPH S sold 25,000 shares of ALHC for $450,000 on Oct 28 ’25. The Director now owns 1,085,973 shares after completing the transaction at $18.00 per share. On Oct 28 ’25, another insider, Joseph Konowiecki, who serves as the Director of the company, bought 25,000 shares for $18.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 3297511936 and an Enterprise Value of 2983089920. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.91 while its Price-to-Book (P/B) ratio in mrq is 20.36. Its current Enterprise Value per Revenue stands at 0.82 whereas that against EBITDA is 82.652.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.18, which has changed by 0.28169012 over the last 52 weeks, in comparison to a change of 0.14151978 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $10.18. The 50-Day Moving Average of the stock is -2.80%, while the 200-Day Moving Average is calculated to be 4.92%.
Shares Statistics:
It appears that ALHC traded 3.28M shares on average per day over the past three months and 2990580 shares per day over the past ten days. A total of 199.99M shares are outstanding, with a floating share count of 159.30M. Insiders hold about 20.39% of the company’s shares, while institutions hold 80.16% stake in the company. Shares short for ALHC as of 1761868800 were 13767170 with a Short Ratio of 4.16, compared to 1759190400 on 14327958. Therefore, it implies a Short% of Shares Outstanding of 13767170 and a Short% of Float of 10.5399996.
Earnings Estimates
. The current market rating for Alignment Healthcare Inc (ALHC) reflects the collective analysis of 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is $0.11, with high estimates of $0.11 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.28 and $0.11 for the fiscal current year, implying an average EPS of $0.21. EPS for the following year is $0.37, with 4.0 analysts recommending between $0.43 and $0.26.
Revenue Estimates
In. The current quarter, 11 analysts expect revenue to total $1B. It ranges from a high estimate of $1.01B to a low estimate of $980M. As of. The current estimate, Alignment Healthcare Inc’s year-ago sales were $701.24MFor the next quarter, 11 analysts are estimating revenue of $1.2B. There is a high estimate of $1.23B for the next quarter, whereas the lowest estimate is $1.17B.
A total of 11 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.94B, while the lowest revenue estimate was $3.9B, resulting in an average revenue estimate of $3.94B. In the same quarter a year ago, actual revenue was $2.7BBased on 11 analysts’ estimates, the company’s revenue will be $5.03B in the next fiscal year. The high estimate is $5.2B and the low estimate is $4.93B.
